These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 9749163)

  • 1. [Influence of some parameters on the blood pressure reduction under treatment: experience from the Hypertension Optimal Treatment Study].
    Mallion JM; Baguet JP; Siché JP; Benkritly A
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1049-53. PubMed ID: 9749163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term clinical tolerance of antihypertensive treatment during the HOT study. Groupe français de l'etude HOT].
    Mallion JM; Dahan R; Boutelant S; Benkritly A; Baguet JP; Noir-Clerc M
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1165-8. PubMed ID: 9404429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Hypertension Optimal Treatment Study: efficacy and tolerability on the 36th month].
    Herpin D; Mallion JM; Benkritly A; Baguet JP; Tremel F
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1043-8. PubMed ID: 9749162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of intensive antihypertensive treatment and of aspirin in a low dose in the hypertensive. The HOT (Hypertension Optimal Treatment) study].
    Mallion JM; Benkritly A; Hansson L; Zanchetti A
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1073-8. PubMed ID: 10486668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actual blood pressure control: are we doing things right?
    Coca A
    J Hypertens Suppl; 1998 Jan; 16(1):S45-51. PubMed ID: 9534097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality of blood pressure control in general practice and in the HOT study. French Research Group HOT (Hypertension Optimal Treatment)].
    Raveau-Landon C
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1179-81. PubMed ID: 8572869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
    Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated systolic hypertension in the elderly: lessons from clinical trials and future directions.
    Black HR
    J Hypertens Suppl; 1999 Dec; 17(5):S49-54. PubMed ID: 10706327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.
    Akram J; Sheikh UE; Mahmood M; Donnelly R
    Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antihypertensive treatment on cardiovascular events in elderly hypertensive patients: Japan's Benidipine Research on Antihypertensive Effects in the Elderly (J-BRAVE).
    Saito I; Suzuki H; Kageyama S; Saruta T
    Clin Exp Hypertens; 2011; 33(2):133-40. PubMed ID: 21269056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension.
    Manyemba J
    Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spanish contribution to the HOT (Hypertension Optimal Treatment) study. Final results. Spanish Investigators in the HOT study].
    Suárez C; Cucala M; Coca A; Ruilope LM
    Med Clin (Barc); 1999 Oct; 113(10):361-5. PubMed ID: 10562937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.